Company / Income Tax
Vir Biotechnology, Inc. Income Tax History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$217.0K
FY2025
5-year range
-$13.1M / $217.0K
FY2021-FY2025
Trend
+119.0%
vs FY2024
Sector context
#98 of 204
Health Care
What the data says
At $217,000, Vir Biotechnology, Inc.'s income tax ranks #107 of 204 in the Health Care sector. Income Tax has fluctuated over the past 9 years, ranging from -$13M in FY2023 to $217,000 in FY2025.
Based on SEC 10-K filings.
$217,000 in FY2025 with a 5-year CAGR of +32.1%.
Increased from -$13M to $217,000 over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- +59.0%
- 5-Year CAGR
- +32.1%
- 10-Year CAGR
- -
Sector benchmark
#107 of 204 in Health CareTop 52% of 204This company $217.0K Sector average $118.7M
▼
-99.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +32.1%, indicating consistent growth.
- In FY2025, income tax increased 119.0% year-over-year.
- Ranks #98 out of 204 companies in the Health Care sector.
- Lowest income tax in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $217.0K | +119.0% |
| FY2024 | -$1.1M | +91.2% |
| FY2023 | -$13.1M | -24316.7% |
| FY2022 | $54.0K | -64.9% |
| FY2021 | $154.0K | +185.2% |
| FY2020 | $54.0K | -64.9% |
| FY2019 | $154.0K | +132.1% |
| FY2018 | -$480.0K | +95.6% |
| FY2017 | -$10.9M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026